What is the prevalence of Lung cancer?

Lung cancer is one of the most common malignancies worldwide, with an estimated 2.2 million new cases diagnosed annually according to the World Health Organization. While not a rare disease, the prevalence of lung cancer varies significantly by region, smoking history, and genetic predispositions, affecting millions of individuals globally at any given time.

Is lung cancer considered a rare disease?

Unlike conditions tracked on rare disease registries, lung cancer is considered a common, high-burden disease. Global incidence is high, though specific molecular subtypes—such as those driven by rare gene mutations like ROS1 or NTRK—are treated with the precision medicine approaches often seen in rare disease research. At DiseaseMaps.org, 53 people with lung cancer have joined our community to share their experiences, providing a vital, real-world perspective on living with this diagnosis.

How does lung cancer affect different populations?

The epidemiology of lung cancer is influenced by several demographic factors:

• Gender: Historically, lung cancer incidence was higher in males; however, these rates have converged in many Western countries due to shifts in smoking patterns.


• Age of Onset: Lung cancer is primarily a disease of older adults, with the median age at diagnosis typically between 65 and 70 years.


• Geographic Variance: Incidence rates are highest in regions with high historical tobacco use and environmental exposure, though non-smokers in East Asia show a distinct, higher prevalence of EGFR-mutated lung cancer compared to other populations.

What challenges exist in tracking lung cancer data?

Accurately measuring the prevalence of lung cancer is complicated by late-stage presentation and diagnostic hurdles. Many patients are asymptomatic until the disease is advanced, leading to significant underdiagnosis in early stages. Furthermore, the distinction between primary lung cancer and metastatic disease from other organs can sometimes lead to reporting discrepancies in global cancer registries.

Next steps

• Consult an oncologist or pulmonologist to discuss screening options if you are at high risk.


• Join the lung cancer community at DiseaseMaps.org to connect with others sharing similar clinical journeys.


• Review your family history with a genetic counselor to determine if you carry hereditary predispositions.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• World Health Organization (WHO): Cancer Fact Sheets.


• American Cancer Society: Cancer Facts & Figures.


• NIH National Cancer Institute (NCI): Surveillance, Epidemiology, and End Results (SEER) Program.


• International Agency for Research on Cancer (IARC): GLOBOCAN database.